Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

Completed · Phase 3 · Has a placebo group

Conditions studied: Pain, Inflammation

In brief

The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment of ocular inflammation and pain in subjects who undergo cataract extraction and intraocular lens implantation.

Key facts

Study ID

NCT00333918

Run by

Bausch & Lomb Incorporated

People needed

522

Starts

2006-06-01

Expected to finish

2007-03-01

Last updated by the study team

2013-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled for unilateral cataract surgery with no other ophthalmic surgical procedures planned during cataract surgery
• Agree to return for all required visits
• Agree to avoid disallowed medications

You may not qualify if…

• Known hypersensitivity to bromfenac and salicylates

Where it is running

• Study site — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.